Recombinant dimeric MHC antigens protect cardiac allografts from rejection and visualize alloreactive T cells

Journal of Leukocyte Biology

Volumn 78, Issue 3, 2005, Pages 595-604

  Fried, Ari ^a   Berg, Martina ^a   Sharma, Bhavna ^b   Bonde, Sabrina ^a   Zavazava, Nicholas ^a,c  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b Gemini Science   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Soluble MHC; Tolerance; Transplantation; Visualization

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DIMER; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN; MONOMER; RECOMBINANT ANTIGEN;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CARDIAC GRAFT REJECTION; CELL LYSATE; CONTROLLED STUDY; DOWN REGULATION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE RESPONSE; IN VITRO STUDY; INTERFERON PRODUCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TARGET CELL;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DIMERIZATION; DISEASE MODELS, ANIMAL; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS; IMMUNOGLOBULIN FC FRAGMENTS; INFUSIONS, PARENTERAL; LYMPHOCYTE ACTIVATION; RATS; RATS, INBRED LEW; RECOMBINANT FUSION PROTEINS; SOLUBILITY; T-LYMPHOCYTES;

AGOUTI;

EID: 24744467774     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0205078     Document Type: Article

References (29)

1. Gill, R., Coulombe, M., Lafferty, K. (1996) Pancreatic islet allograft immunity and tolerance: the two-signal hypothesis revisited. Immunol. Rev. 149, 75-96.
2. June, C., Bluestone, J., Nadler, L., Thompson, C. (1994) The B7 and CD28 receptor families. Immunol. Today 15, 321-331.
3. Shoskes, D., Wood, K. (1994) Indirect presentation of MHC antigens in transplantation. Immunol. Today 15, 32-38.
4. Haga, J., She, J., Kao, K. (1991) Biochemical characterization of 39-kDa class I histocompatibility antigen in plasma. J. Biol. Chem. 266, 3695-3701.
5. Kao, K., Scornik, J., Riley, W., McQueen, C. (1988) Association between phenotype and HLA concentration in plasma and platelets. Hum. Immunol. 21, 115-124.
6. Zavazava, N., Westphal, E., Mueller-Ruchholtz, W. (1990) Characterization of soluble HLA molecules in sweat and quantitative HLA differences in serum of healthy individuals. J. Immunogenetics 17, 387-394.
7. Pouletty, P., Chang, C., Kalil, J., Atwood, E., Ferrone, S., Shimizu, B., Howson, W., Mazaheri, R., Villano, B., Grumet, C. (1993) Typing of serum-soluble HLA-B27 antigen by ELISA. Tissue Antigens 42, 14-19.
8. Zavazava, N., Böttcher, H., Mueller-Ruchholtz, W. (1993) Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients. Tissue Antigens 42, 20-26.
9. Behrens, D., Lange, K., Fried, A., Yoo-Ott, K., Richter, K., Fändrich, F., Krönke, M., Zavazava, N. (2001) Donor-derived soluble MHC antigens plus low-dose cyclosporine induce transplantation unresponsiveness independent of the thymus by down-regulating T cell-mediated alloresponses in a rat transplantation model. Transplantation 72, 1974-1982.
10. Schneck, J., Sechler, J., O'Herrin, S., Bieler, J., Barues, N., Rosenberg, A. (1996) Specific inhibition of graft rejection by soluble MHC superdimers. Human Immunol. 47, 149.
11. O'Herrin, S. M., Slansky, J., Tang, Q., Markiewicx, M., Gajewski, T., Pardoll, D., Schneck, J., Bluestone, J. (2001) Antigen-specific blockage of T cells in vivo using dimeric MHC peptide. J. Immunol. 167, 2555-2560.
12. Casares, S., Hurtado, A., McEvoy, R. C., Sarukhan, A., von Boehmer, H., Brumeanu, T. D. (2002) Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide-MHC class II chimera. Nat. Immunol. 3, 383-391.
13. Ono, K., Lindsey, E. (1969) Improved technique of heart transplantation in rats. J. Thorac. Cardiovasc. Surg. 57, 225-229.
14. Fändrich, F., Zhu, X., Schröder, J., Dresske, B., Henne-Bruns, D., Oswald, H., Zavazava, N. (1999) Different in vivo tolerogenicity of MHC class I peptides. J. Leukoc. Biol. 65, 16-27.
15. Freese, A., Zavazava, N. (2002) HLA-B7 β-pleated sheet-derived synthetic peptides are immunodominant T-cell epitopes regulating alloresponses. Blood 99, 3286-3292.
16. Zavazava, N., Hausmann, R., Mueller-Ruchholtz, W. (1991) Inhibition of anti-HLAB7 alloreactive CTL by affinity-purified soluble HLA. Transplantation 51, 838-842.
17. Charlton, R., Zmijewski, C. (1970) Soluble HL-A7 antigen; localization in the β-lipoprotein fraction of human serum. Science 170, 636-637.
18. Freese, A., Zavazava, N. (1996) Determination of HLA-B7 T-cell epitopes. Transpl. Int. 9 (Suppl. 1), S352-S355.
19. Zavazava, N., Krönke, M. (1996) Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nat. Med. 2, 1005-1010.
20. Altman, J., Moss, P., Goulder, P., Barouch, D., McHeyzer-Williams, M., Bell, J., McMichael, A., Davis, M. (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94-96.
21. Hausmann, R., Zavazava, N., Steinmann, J., Mueller-Ruchholtz, W. (1993) Interaction of papain-digested HLA class I molecules with human alloreactive cytotoxic T lymphocytes (CTL). Clin. Exp. Immunol. 91, 183-188.
22. Abastado, J., Lone, Y., Casrouge, A., Boulot, C., Kourilsky, P. (1995) Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness. J. Exp. Med. 182, 439-447.
23. Obst, K., Netuschil, N., Klopfer, K., Stevanovic, S., Rammensee, H. G. (2000) The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules. J. Exp. Med. 191, 805-812.
24. Barnea, E., Beer, I., Patoka, R., Ziv, T., Kessler, O., Tzehoval, E., Eisenbach, L., Zavazava, N., Admon, A. (2002) Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor-specific antigens. Eur. J. Immunol. 32, 213-222.
25. Zavazava, N., Fändrich, K., Zhu, X., Freese, A., Behrens, D., Yoo-Ott, K. (2000) Oral feeding of an immunodominant MHC-donor-derived synthetic class I peptide prolongs graft survival of heterotopic cardiac allografts in a high-responder rat strain combination. J. Leukoc. Biol. 67, 793-800.
26. Murphy, H., Mage, C. Alexander, S., Waaga, A., Snoeck, M., Vella, J., Carpenter, C., Sayegh, M. (1999) Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis. J. Clin. Invest. 103, 859-867.
27. Chowdhury, N. C., Sahorio, D. V., Garrovillo, M., Chandraker, A., Magee, C. C., Waaga, A. M., Sayegh, M. H., Jin, M. X., Oluwole, S. F. (1998) Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) all-MHC class I (RT1.AU) peplide or WAG (RT1U)-derived class 1 peptide. Transplantation 66, 1059-1066.
28. Oluwole, S., Jin, M., Chowdhury, N., Ohajekwe, O. (1994) Effectiveness of intrathymic inoculation of soluble antigens in the induction of specific unresponsiveness to rat islet allografts without transient recipient immunosuppresssion. Transplantation 58, 1077-1081.
29. Skinner, P., Daniels, M., Schmidt, C., Jameson, S., Haase, A. (2000) Cutting edge: in situ tetramer staining of antigen-specific T cells in tissues. J. Immunol. 165, 613-617.